Both human and mouse liver TMEM127 expression correlate with states of insulin resistance and advanced hepatic steatosis, suggesting that TMEM127 may be a relevant target for treating insulin resistance and its hepatic complications. The gene discussed is TMEM127; the disease is fatty liver disease.